Nexus -
info_outline
Stay signed in to save your points and redeem your rewards at Nexus

Your Rewards are Waiting!

Stay signed in to save the points you've earned. Click on the points to redeem your rewards at Nexus before they expire.

Login In Now
Star Biz7

The great recovery

By DOREENN LEONG

IT was a bitter pill for investors when Pharmaniaga Bhd plunged into Practice Note 17 (PN17) status in 2023 after a massive Covid-19 vaccine impairment shattered earnings and eroded market confidence.

Few expected the government-linked pharmaceutical group to recover so quickly.

The Star 6.6 DEAL: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , Biopharmaceuticals , InsulinManufacturing , HealthcareSector , VaccineDevelopment , DiabetesCare , HealthcareSecurity , TurnaroundStory

Next In Business News
AIM to explore business development with Beijing ZhenHealth Tech
Forest City SFZ can exceed RM2bil investment target this year
Weststar Maxus, Yinson Greentech ink deal for 300 electric commercial vans
Wawasan QI's Kami Builders issues RM90mil SRI sukuk
Heavyweight stocks lift Bursa Malaysia, pare losses at midday
Datuk Halipah Esa retires from SD Guthrie's sustainability and board tender committees
B15 biodiesel rollout could east inflation, reduce fiscal burden - CGS International
i-City partners TwinMatrix on developing AI-enhanced experiential AI living
Tanco hits limit down for third straight day, prompts further IDSS suspension
Japan's Nikkei recoups early losses as US signals end of Iran strikes

Trending in Business

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.